The future of azole use in epidemiology involves balancing the benefits of these drugs with the risks of resistance. Continued research and development of new antifungal agents, improved diagnostic techniques, and enhanced surveillance systems are crucial. Public health initiatives aimed at promoting appropriate use and mitigating resistance will be essential for maintaining the efficacy of azoles.
